Table 8. Essential Characteristice of Anti-Zika Virus NS1 Monoclonal Antibodies
Epitope
Group

A

B

C

D

E

F
Cross react toFlavivirus NS1
proteins(recombinant)Flavivirus NS1
common Ab
Dengue NS1 specific

Cat No.

Clone No.

Mouse
Ig
Isotype

Reactivity in CELIXSYS* method (%): Ab conc. = 10μg/mL

Ag-ELISA method (A490nm)

Native NS1 proteins

Recombinat Proteins

Cross Reactivity to other NS1 proteinsZIKV NS1
Paraiba

RGN

DENV1

DENV2

DENV3

DENV4

JEV

ZIKV
NS1

Epitope analysis based on
antibody inhibition teston Ag-ELISA method

Cross Reactivity to other NS1 proteins

DENV1

DENV2

DENV3

DENV4

JEV

WNV

YFV

Inhibitiion ratio
to each biotinylated antibody
in %ZK1ZK1ZK12486
1726
852

BMRzk024

ZK1-2508

IgG2a

98

96

0

2

0

0

5

3.571

0.051

0.049

0.050

0.049

0.053

0.074

0.049

89

95

4

BMRzk015

ZK1-1690

IgG1

85

73

0

2

0

0

0

3.022

0.053

0.049

0.050

0.049

0.049

0.073

0.048

91

97

6

BMRzk014

ZK1-1589

IgG1

82

83

4

3

0

3

0

2.522

0.049

0.047

0.048

0.047

0.048

0.063

0.048

88

96

7

BMRzk012

ZK1-1303

IgG1

82

82

5

3

5

2

0

2.206

0.048

0.046

0.046

0.046

0.047

0.057

0.046

94

99

8

BMRzk023

ZK1-2486

IgG2b

91

90

0

1

0

0

3

3.718

0.054

0.049

0.048

0.048

0.050

0.157

0.049

93

69

2

BMRzk017

ZK1-1726

IgG1

76

80

2

3

1

0

0

1.984

0.046

0.046

0.046

0.058

0.053

0.053

0.053

64

87

6

BMRzk027

ZK2-136

IgG1

75

80

7

2

1

5

0

2.213

0.055

0.057

0.057

0.051

0.051

0.073

0.050

83

75

5

BMRzk034

ZK3-1023

IgG1

78

76

4

3

1

9

0

1.981

0.055

0.056

0.055

0.055

0.056

0.108

0.054

84

73

7

BMRzk035

ZK3-1315

IgG1

75

81

5

0

2

4

0

2.911

0.051

0.049

0.049

0.053

0.050

0.096

0.053

91

69

4

BMRzk002

ZK1-311

IgG2a

96

98

1

1

2

0

5

3.382

0.050

0.048

0.048

0.048

0.049

0.165

0.047

81

66

3

BMRzk007

ZK1-1112

IgG1

85

76

0

0

0

0

0

2.135

0.048

0.057

0.050

0.048

0.050

0.083

0.049

80

58

0

BMRzk028

ZK2-639

IgG2a

95

96

4

4

5

8

1

2.083

0.050

0.048

0.051

0.052

0.051

0.053

0.050

29

26

4

BMRzk013

ZK1-1309

IgG1

82

80

4

3

5

4

0

1.099

0.048

0.047

0.047

0.046

0.047

0.068

0.048

36

32

2

BMRzk011

ZK1-1274

IgG1

78

80

4

3

5

0

0

1.182

0.051

0.047

0.048

0.047

0.048

0.059

0.047

32

35

2

BMRzk029

ZK2-1467

IgG1

74

75

4

4

6

9

0

1.166

0.050

0.050

0.050

0.051

0.048

0.052

0.050

30

21

5

BMRzk030

ZK3-69

IgG2a

96

96

8

7

6

10

3

3.307

0.049

0.049

0.050

0.050

0.052

0.066

0.050

0

73

10

BMRzk019

ZK1-1959

IgG2b

86

74

1

1

4

0

5

3.846

0.047

0.046

0.046

0.048

0.048

0.104

0.048

0

46

8

BMRzk001

ZK1-52

IgG2a

93

98

6

3

3

0

9

3.735

0.050

0.047

0.047

0.049

0.053

0.077

0.056

0

44

7

BMRzk008

ZK1-1194

IgG1

86

75

1

1

0

0

0

3.785

0.050

0.050

0.049

0.050

0.050

0.180

0.049

40

51

72

BMRzk018

ZK1-1750

IgG1

77

82

2

0

0

0

0

3.781

0.055

0.093

0.100

0.049

0.048

0.131

0.048

14

31

92

BMRzk010

ZK1-1254

IgG1

77

81

2

3

4

0

0

3.680

0.054

0.050

0.049

0.048

0.047

0.068

0.048

15

39

56

BMRzk009

ZK1-1237

IgG1

80

82

6

5

2

0

0

3.679

0.047

0.048

0.047

0.048

0.049

0.096

0.051

14

21

28

BMRzk025

ZK1-2597

IgG2a

91

97

0

3

1

0

9

3.558

0.047

0.047

0.050

0.047

0.049

0.050

0.052

13

17

26

BMRzk020

ZK1-2271

IgG1

80

82

5

3

10

1

0

3.824

0.048

0.046

0.048

0.047

0.047

0.154

0.047

15

40

15

BMRzk032

ZK3-736

IgG1

86

86

6

6

4

10

9

3.831

0.050

0.052

0.050

0.052

0.053

0.116

0.052

25

32

14

BMRzk033

ZK3-943

IgG1

76

76

5

7

4

11

0

3.890

0.051

0.050

0.050

0.051

0.050

0.228

0.050

49

49

95

BMRzk031

ZK3-679

IgG2a

98

98

2

1

0

2

0

3.610

0.048

0.046

0.045

0.049

0.044

0.449

0.046

45

44

95

BMRzk022

ZK1-2460

IgG2a

98

96

1

3

3

4

11

3.920

0.061

0.194

0.165

0.080

0.046

0.241

0.048

32

41

97

BMRzk005

ZK1-852

IgG2a

98

99

5

5

0

1

8

3.943

0.061

0.313

0.286

0.087

0.051

0.306

0.047

37

49

97

BMRzk026

ZK2-134

IgG1

73

80

3

0

0

2

0

3.737

0.431

0.048

0.050

0.632

0.050

0.144

0.060

41

42

93

BMRzk006

ZK1-866

IgG2b

93

91

4

11

0

2

3

3.923

0.103

1.893

1.859

0.991

0.049

0.379

0.047

40

50

99

BMRzk003

ZK1-356

IgG2a

96

99

5

2

1

0

7

3.850

0.058

0.047

0.049

0.048

0.050

0.998

0.048

24

22

97

BMRzk004

ZK1-604

IgG2a

95

99

4

4

5

3

8

3.903

0.049

0.049

0.048

0.077

0.051

1.011

0.046

35

50

59

BMRzk016

ZK1-1725

IgG1

86

72

0

1

0

0

0

3.833

0.059

0.052

0.051

0.051

0.062

0.215

0.049

39

53

21

DEN5-380

IgG2a

98

99

101

100

100

100

99

3.303

3.678

3.669

3.654

3.544

2.920

3.459

2.205

83

84

6

DEN1-1232

IgG1

5

4

93

100

93

100

5

0.065

3.307

3.681

3.672

3.561

0.076

0.049

0.090

0

0

0

Assay Control* The CELIXSYS method is an immuno-precipitation-equivalent screening method. The figure (expressed in %) represents the strength of reactivity of monoclonal antibodies to each NS1 protein of Flavi viruses.
The numbers expressed in % represent a strength of reactivity of monoclonal antibodies to each NS1 protein of Flavi viruses. The higher the number, the stronger the reactivity of antibody.

Summary of Technical Data Sheet for BMR Anti-Influenza A Monoclonal Antibody＊Contact us for matching pairs

Product Name

Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody

BMR Catalog No.

BMRzk001

BMRzk002

BMRzk003

BMRzk004

BMRzk005

BMRzk006

BMRzk007

BMRzk008

Clone Number

ZK1-52

ZK1-311

ZK1-356

ZK1-604

ZK1-852

ZK1-866

ZK1-1112

ZK1-1194

Lot Number

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Isotype

IgG2a

IgG2a

IgG2a

IgG2a

IgG2a

IgG2b

IgG1

IgG1

Concentration

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host

Immunogen

Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Specificity

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Some cross-reactivity with recombinant
NS1 protein of West Nie virus (WNV).
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV) andYellow fever virus (YFV).

Some cross-reactivity with recombinant
NS1 protein of West Nie virus (WNV).
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV) andYellow fever virus (YFV).

Slight cross-reactivity with recombinant
NS1 proteins of DENV-2, DENV-3 andWest Nie virus (WNV).
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-4, Japanese encephalitis
virus (JEV) and Yellow fever virus(YFV).

Some cross-reactivity with recombinant
NS1 proteins of DENV-2, DENV-3,
DENV-4 and West Nie virus (WNV).
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, Japanese encephalitis virus(JEV) and Yellow fever virus (YFV).

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Cross Reactivity

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Grade & Purity

In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95%(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).

Form & Buffer

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Storage

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Method of Purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Size

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

Contaminants

NA

NA

NA

NA

NA

NA

NA

NA

Preservative

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

Biohazard
Information

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

Bio Matrix Reseach Inc.

Summary of Technical Data Sheet for BMR Anti-Influenza A Monoclonal Antibody＊Contact us for matching pairs

Product Name

Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody

BMR Catalog No.

BMRzk009

BMRzk010

BMRzk011

BMRzk012

BMRzk013

BMRzk014

BMRzk015

BMRzk016

Clone Number

ZK1-1237

ZK1-1254

ZK1-1274

ZK1-1303

ZK1-1309

ZK1-1589

ZK1-1690

ZK1-1725

Lot Number

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Isotype

IgG1

IgG1

IgG1

IgG1

IgG1

IgG1

IgG1

IgG1

Concentration

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host

Immunogen

Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Specificity

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Cross Reactivity

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Slight cross-reactivity with recombinant
NS1 protein of West Nie virus (WNV).
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV) andYellow fever virus (YFV).

Grade & Purity

In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95%(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).

Form & Buffer

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Storage

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Method of Purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Size

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

Contaminants

NA

NA

NA

NA

NA

NA

NA

NA

Preservative

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

Biohazard
Information

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

Bio Matrix Reseach Inc.

Summary of Technical Data Sheet for BMR Anti-Influenza A Monoclonal Antibody＊Contact us for matching pairs

Product Name

Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody

BMR Catalog No.

BMRzk017

BMRzk018

BMRzk019

BMRzk020

BMRzk022

BMRzk023

BMRzk024

BMRzk025

Clone Number

ZK1-1726

ZK1-1750

ZK1-1959

ZK1-2271

ZK1-2460

ZK1-2486

ZK1-2508

ZK1-2597

Lot Number

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Isotype

IgG1

IgG1

IgG2b

IgG1

IgG2a

IgG2b

IgG2a

IgG2a

Concentration

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host

Immunogen

Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Specificity

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Cross Reactivity

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Slight cross-reactivity with recombinant
NS1 protein of West Nie virus (WNV).
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV) andYellow fever virus (YFV).

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Grade & Purity

In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95%(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).

Form & Buffer

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Storage

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Method of Purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Size

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

Contaminants

NA

NA

NA

NA

NA

NA

NA

NA

Preservative

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

Biohazard
Information

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

Bio Matrix Reseach Inc.

Summary of Technical Data Sheet for BMR Anti-Influenza A Monoclonal Antibody＊Contact us for matching pairs

Product Name

Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody

BMR Catalog No.

BMRzk026

BMRzk027

BMRzk028

BMRzk029

BMRzk030

BMRzk031

BMRzk032

BMRzk033

Clone Number

ZK2-134

ZK2-136

ZK2-639

ZK2-1467

ZK3-69

ZK3-679

ZK3-736

ZK3-943

Lot Number

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Depend on the purification Lot

Isotype

IgG1

IgG1

IgG2a

IgG1

IgG2a

IgG2a

IgG1

IgG1

Concentration

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host

Immunogen

Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Zika NS1 (Recombinant)Specificity

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Cross Reactivity

Some cross-reactivity with recombinant
NS1 proteins of DENV-1 and DENV-4.
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-2, DENV-3, Japanese encephalitis
virus (JEV), West Nile virus (WNV) andYellow fever virus (YFV).

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Slight cross-reactivity with recombinant
NS1 protein of West Nie virus (WNV).
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV) andYellow fever virus (YFV).

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Slight cross-reactivity with recombinant
NS1 protein of West Nie virus (WNV).
No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4, Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV) andYellow fever virus (YFV).

Grade & Purity

In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95%(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).

Form & Buffer

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Storage

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Store at 2-8℃

Method of Purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Protein A affinity purification

Size

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

1mg ～

Contaminants

NA

NA

NA

NA

NA

NA

NA

NA

Preservative

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

0.05% NaN3

Biohazard
Information

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

Bio Matrix Reseach Inc.

Summary of Technical Data Sheet for BMR Anti-Influenza A Monoclonal Antibody＊Contact us for matching pairs

Product Name

Anti-Zika virus NS1 Monoclonal Antibody Anti-Zika virus NS1 Monoclonal Antibody

BMR Catalog No.

BMRzk034

BMRzk035

Clone Number

ZK3-1023

ZK3-1315

Lot Number

Depend on the purification Lot

Depend on the purification Lot

Isotype

IgG1

IgG1

Concentration

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

1 ~ 5 mg/mL
Depend on the purification Lot(5mg/mL for most lots)

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host : Mouse.
Hybridization of P3X63.Ag8.653
myeloma cells with spleen cells from
BALB/c mice.
Source : Ascites

Host

Immunogen

Zika NS1 (Recombinant)Zika NS1 (Recombinant)Specificity

Reactive to native and recombinant NS1
proteins of Zika virus

Reactive to native and recombinant NS1
proteins of Zika virus

Cross Reactivity

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

No cross-reactivity with native NS1
proteins of DENV-1, DENV-2, DENV-3,
DENV-4 and Japanese encephalitis virus(JEV) and recombinant NS1 proteins of
DENV-1, DENV-2, DENV-3, DENV-4,
Japanese encephalitis virus (JEV), West
Nile virus (WNV) and Yellow fever virus(YFV) .

Grade & Purity

In vitro use only. Purity is more than 95% In vitro use only. Purity is more than 95%(SDS-PAGE or HPLC).
(SDS-PAGE or HPLC).

Form & Buffer

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Protein A affinity purified and supplied asa liquid in PBS(-); pH7.4, 3.0mM KCl,
1.5mM KH2PO4, 140mM NaCl, 8.0mM
Na2HPO4

Storage

Store at 2-8℃

Store at 2-8℃

Method of Purification

Protein A affinity purification

Protein A affinity purification

Size

1mg ～

1mg ～

Contaminants

NA

NA

Preservative

0.05% NaN3

0.05% NaN3

Biohazard
Information

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

This product contains 0.05% sodium
azide as a preservative. Although theamount of sodium azide is very small
appropriate care must be taken whenhandling.

Bio Matrix Reseach Inc.